Upadacitinib
Showing 26 - 50 of 90
Rheumatoid Arthritis Patients Treated With JAK-inhibitor
Recruiting
- Rheumatoid Arthritis
- Upadacitinib <15 MG [Rinvoq]
-
Montpellier, FranceCHU de Montpellier
Jan 12, 2022
Non-Segmental Vitiligo Trial in Worldwide (Upadacitinib, Placebo)
Active, not recruiting
- Non-Segmental Vitiligo
- Upadacitinib
- Placebo
-
Irvine, California
- +34 more
Jan 31, 2023
Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)
Not yet recruiting
- Rheumatoid Arthritis
- Anti-TNF
- JAK inhibitor
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
May 17, 2022
Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)
Recruiting
- Takayasu Arteritis (TAK)
- Upadacitinib
- +2 more
-
Salvador, Bahia, Brazil
- +44 more
Aug 22, 2022
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023
Rheumatoid Arthritis Trial (Upadacitinib, Adalimumab)
Not yet recruiting
- Rheumatoid Arthritis
- Upadacitinib
- Adalimumab
- (no location specified)
Nov 29, 2021
Disease Activity and Treatment Patterns of Upadacitinib When
Recruiting
- Psoriatic Arthritis
-
TOULOUSE Cedex 9, Haute-Garonne, France
- +33 more
Jan 25, 2023
Disease Activity and Use of Upadacitinib Tablets in Adolescent
Not yet recruiting
- Atopic Dermatitis
-
St Quentin CEDEX, Aisne, France
- +41 more
Dec 21, 2022
Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)
Terminated
- Rheumatoid Arthritis (RA)
- Elsubrutinib
- +3 more
-
Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
- +29 more
Aug 18, 2021
Assess Disease Activity in Adult Ankylosing Spondylitis Who
Recruiting
- Radiographic Axial Spondylarthritis (r-axSpA)
- Upadacitinib
-
Ulm, Baden-Wuerttemberg, Germany
- +69 more
Aug 8, 2022
Ulcerative Colitis Trial in Worldwide (Upadacitinib)
Not yet recruiting
- Ulcerative Colitis
- Upadacitinib
-
Boston, Massachusetts
- +62 more
Mar 13, 2023
Disease State of Oral Upadacitinib in Adolescent Participants
Recruiting
- Atopic Dermatitis
-
Ichinomiya-shi, Aichi, Japan
- +35 more
Jul 27, 2022
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Real World Effectiveness of Upadacitinib as Monotherapy or in
Completed
- Rheumatoid Arthritis (RA)
-
Ulm, Baden-Wuerttemberg, Germany
- +51 more
Mar 10, 2022
Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)
Completed
- Rheumatoid Arthritis (RA)
- Upadacitinib
- Placebo
-
Curitiba, Parana, Brazil
- +42 more
Aug 30, 2021
Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)
Systemic Lupus Erythematosus Trial in Worldwide (Upadacitinib, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Upadacitinib
- Placebo
-
Flagstaff, Arizona
- +257 more
Apr 25, 2023
Assess Disease Activity in Adolescent and Adult Atopic
Recruiting
- Atopic Dermatitis
-
Heidelberg, Baden-Wuerttemberg, Germany
- +99 more
Nov 24, 2022
Disease State in Adult Participants Being Treated With Oral
Recruiting
- Psoriatic Arthritis
-
Vancouver, British Columbia, Canada
- +91 more
Dec 14, 2022
Atopic Dermatitis Trial in Worldwide (Upadacitinib)
Active, not recruiting
- Atopic Dermatitis
- Upadacitinib
-
Little Rock, Arkansas
- +115 more
Jul 27, 2022